377 related articles for article (PubMed ID: 31982409)
1. Identification of Lineage-Specific Transcription Factors That Prevent Activation of Hepatic Stellate Cells and Promote Fibrosis Resolution.
Liu X; Xu J; Rosenthal S; Zhang LJ; McCubbin R; Meshgin N; Shang L; Koyama Y; Ma HY; Sharma S; Heinz S; Glass CK; Benner C; Brenner DA; Kisseleva T
Gastroenterology; 2020 May; 158(6):1728-1744.e14. PubMed ID: 31982409
[TBL] [Abstract][Full Text] [Related]
2. P300 Acetyltransferase Mediates Stiffness-Induced Activation of Hepatic Stellate Cells Into Tumor-Promoting Myofibroblasts.
Dou C; Liu Z; Tu K; Zhang H; Chen C; Yaqoob U; Wang Y; Wen J; van Deursen J; Sicard D; Tschumperlin D; Zou H; Huang WC; Urrutia R; Shah VH; Kang N
Gastroenterology; 2018 Jun; 154(8):2209-2221.e14. PubMed ID: 29454793
[TBL] [Abstract][Full Text] [Related]
3. Lipopolysaccharide Reverses Hepatic Stellate Cell Activation Through Modulation of cMyb, Small Mothers Against Decapentaplegic, and CCAAT/Enhancer-Binding Protein C/EBP Transcription Factors.
Sharma A; Verma AK; Kofron M; Kudira R; Miethke A; Wu T; Wang J; Gandhi CR
Hepatology; 2020 Nov; 72(5):1800-1818. PubMed ID: 32064648
[TBL] [Abstract][Full Text] [Related]
4. SIRT1 antagonizes liver fibrosis by blocking hepatic stellate cell activation in mice.
Li M; Hong W; Hao C; Li L; Wu D; Shen A; Lu J; Zheng Y; Li P; Xu Y
FASEB J; 2018 Jan; 32(1):500-511. PubMed ID: 28970250
[TBL] [Abstract][Full Text] [Related]
5. CPEB4 Increases Expression of PFKFB3 to Induce Glycolysis and Activate Mouse and Human Hepatic Stellate Cells, Promoting Liver Fibrosis.
Mejias M; Gallego J; Naranjo-Suarez S; Ramirez M; Pell N; Manzano A; Suñer C; Bartrons R; Mendez R; Fernandez M
Gastroenterology; 2020 Jul; 159(1):273-288. PubMed ID: 32169429
[TBL] [Abstract][Full Text] [Related]
6. Aryl Hydrocarbon Receptor Signaling Prevents Activation of Hepatic Stellate Cells and Liver Fibrogenesis in Mice.
Yan J; Tung HC; Li S; Niu Y; Garbacz WG; Lu P; Bi Y; Li Y; He J; Xu M; Ren S; Monga SP; Schwabe RF; Yang D; Xie W
Gastroenterology; 2019 Sep; 157(3):793-806.e14. PubMed ID: 31170413
[TBL] [Abstract][Full Text] [Related]
7. Hedgehog-YAP Signaling Pathway Regulates Glutaminolysis to Control Activation of Hepatic Stellate Cells.
Du K; Hyun J; Premont RT; Choi SS; Michelotti GA; Swiderska-Syn M; Dalton GD; Thelen E; Rizi BS; Jung Y; Diehl AM
Gastroenterology; 2018 Apr; 154(5):1465-1479.e13. PubMed ID: 29305935
[TBL] [Abstract][Full Text] [Related]
8. Single-Cell Transcriptomic Analysis Reveals a Hepatic Stellate Cell-Activation Roadmap and Myofibroblast Origin During Liver Fibrosis in Mice.
Yang W; He H; Wang T; Su N; Zhang F; Jiang K; Zhu J; Zhang C; Niu K; Wang L; Yuan X; Liu N; Li L; Wei W; Hu J
Hepatology; 2021 Nov; 74(5):2774-2790. PubMed ID: 34089528
[TBL] [Abstract][Full Text] [Related]
9. Rosiglitazone Inhibits Activation of Hepatic Stellate Cells via Up-Regulating Micro-RNA-124-3p to Alleviate Hepatic Fibrosis.
Zhi SC; Chen SZ; Li YY; Li JJ; Zheng YH; Yu FX
Dig Dis Sci; 2019 Jun; 64(6):1560-1570. PubMed ID: 30673982
[TBL] [Abstract][Full Text] [Related]
10. Cell-specific PPARγ deficiency establishes anti-inflammatory and anti-fibrogenic properties for this nuclear receptor in non-parenchymal liver cells.
Morán-Salvador E; Titos E; Rius B; González-Périz A; García-Alonso V; López-Vicario C; Miquel R; Barak Y; Arroyo V; Clària J
J Hepatol; 2013 Nov; 59(5):1045-53. PubMed ID: 23831119
[TBL] [Abstract][Full Text] [Related]
11. Peroxisome proliferated-activated receptor gamma ligand, Pioglitazone, does not prevent hepatic fibrosis in mice.
Da Silva Morais A; Abarca-Quinones J; Horsmans Y; Stärkel P; Leclercq IA
Int J Mol Med; 2007 Jan; 19(1):105-12. PubMed ID: 17143554
[TBL] [Abstract][Full Text] [Related]
12. Histone H3K9 demethylase JMJD1A modulates hepatic stellate cells activation and liver fibrosis by epigenetically regulating peroxisome proliferator-activated receptor γ.
Jiang Y; Wang S; Zhao Y; Lin C; Zhong F; Jin L; He F; Wang H
FASEB J; 2015 May; 29(5):1830-41. PubMed ID: 25609425
[TBL] [Abstract][Full Text] [Related]
13. Deactivation of hepatic stellate cells during liver fibrosis resolution in mice.
Troeger JS; Mederacke I; Gwak GY; Dapito DH; Mu X; Hsu CC; Pradere JP; Friedman RA; Schwabe RF
Gastroenterology; 2012 Oct; 143(4):1073-83.e22. PubMed ID: 22750464
[TBL] [Abstract][Full Text] [Related]
14. EphB2 receptor tyrosine kinase promotes hepatic fibrogenesis in mice via activation of hepatic stellate cells.
Mimche PN; Lee CM; Mimche SM; Thapa M; Grakoui A; Henkemeyer M; Lamb TJ
Sci Rep; 2018 Feb; 8(1):2532. PubMed ID: 29416088
[TBL] [Abstract][Full Text] [Related]
15. Coordinated signaling of activating transcription factor 6α and inositol-requiring enzyme 1α regulates hepatic stellate cell-mediated fibrogenesis in mice.
Xue F; Lu J; Buchl SC; Sun L; Shah VH; Malhi H; Maiers JL
Am J Physiol Gastrointest Liver Physiol; 2021 May; 320(5):G864-G879. PubMed ID: 33728997
[TBL] [Abstract][Full Text] [Related]
16. Fibrogenic Activity of MECP2 Is Regulated by Phosphorylation in Hepatic Stellate Cells.
Moran-Salvador E; Garcia-Macia M; Sivaharan A; Sabater L; Zaki MYW; Oakley F; Knox A; Page A; Luli S; Mann J; Mann DA
Gastroenterology; 2019 Nov; 157(5):1398-1412.e9. PubMed ID: 31352003
[TBL] [Abstract][Full Text] [Related]
17. ECM1 Prevents Activation of Transforming Growth Factor β, Hepatic Stellate Cells, and Fibrogenesis in Mice.
Fan W; Liu T; Chen W; Hammad S; Longerich T; Hausser I; Fu Y; Li N; He Y; Liu C; Zhang Y; Lian Q; Zhao X; Yan C; Li L; Yi C; Ling Z; Ma L; Zhao X; Xu H; Wang P; Cong M; You H; Liu Z; Wang Y; Chen J; Li D; Hui L; Dooley S; Hou J; Jia J; Sun B
Gastroenterology; 2019 Nov; 157(5):1352-1367.e13. PubMed ID: 31362006
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-194 inactivates hepatic stellate cells and alleviates liver fibrosis by inhibiting AKT2.
Wu JC; Chen R; Luo X; Li ZH; Luo SZ; Xu MY
World J Gastroenterol; 2019 Aug; 25(31):4468-4480. PubMed ID: 31496625
[TBL] [Abstract][Full Text] [Related]
19. GLIS2 Prevents Hepatic Fibrosis by Competitively Binding HDAC3 to Inhibit Hepatic Stellate Cell Activation.
Zhang H; Zhou P; Xing W; Chen L; Zhou Y; Yang H; Fu K; Liu Z
Cell Mol Gastroenterol Hepatol; 2023; 15(2):355-372. PubMed ID: 36397300
[TBL] [Abstract][Full Text] [Related]
20. Glabridin inhibits liver fibrosis and hepatic stellate cells activation through suppression of inflammation and oxidative stress by activating PPARγ in carbon tetrachloride-treated mice.
Zhang L; Zhang H; Gu J; Xu W; Yuan N; Sun J; Li H
Int Immunopharmacol; 2022 Dec; 113(Pt B):109433. PubMed ID: 36371863
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
